The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Outsourcing in Drug Discovery Market Research Report 2025
Synopsis
Drug discovery outsourcing refers to the outsourcing of drug discovery processes to contract manufacturers to reduce the time taken for development of a drug or to scale-up production, enjoy premium pricing, increase market share, reduce costs and serve the local markets.
The global Outsourcing in Drug Discovery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Outsourcing in Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Outsourcing in Drug Discovery.
Report Scope
The Outsourcing in Drug Discovery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Outsourcing in Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Outsourcing in Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
ICON
Parexel
PPD
PRA Health Sciences
Wuxi AppTec
Recipharm
Segment by Type
Small Molecules
Large Molecules
Segment by Application
Hospitals and Clinics
Medical Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Outsourcing in Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Drug discovery outsourcing refers to the outsourcing of drug discovery processes to contract manufacturers to reduce the time taken for development of a drug or to scale-up production, enjoy premium pricing, increase market share, reduce costs and serve the local markets.
The global Outsourcing in Drug Discovery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Outsourcing in Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Outsourcing in Drug Discovery.
Report Scope
The Outsourcing in Drug Discovery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Outsourcing in Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Outsourcing in Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
ICON
Parexel
PPD
PRA Health Sciences
Wuxi AppTec
Recipharm
Segment by Type
Small Molecules
Large Molecules
Segment by Application
Hospitals and Clinics
Medical Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Outsourcing in Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Outsourcing in Drug Discovery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Small Molecules
1.2.3 Large Molecules
1.3 Market by Application
1.3.1 Global Outsourcing in Drug Discovery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Medical Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Outsourcing in Drug Discovery Market Perspective (2019-2030)
2.2 Outsourcing in Drug Discovery Growth Trends by Region
2.2.1 Global Outsourcing in Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Outsourcing in Drug Discovery Historic Market Size by Region (2019-2024)
2.2.3 Outsourcing in Drug Discovery Forecasted Market Size by Region (2025-2030)
2.3 Outsourcing in Drug Discovery Market Dynamics
2.3.1 Outsourcing in Drug Discovery Industry Trends
2.3.2 Outsourcing in Drug Discovery Market Drivers
2.3.3 Outsourcing in Drug Discovery Market Challenges
2.3.4 Outsourcing in Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Outsourcing in Drug Discovery Players by Revenue
3.1.1 Global Top Outsourcing in Drug Discovery Players by Revenue (2019-2024)
3.1.2 Global Outsourcing in Drug Discovery Revenue Market Share by Players (2019-2024)
3.2 Global Outsourcing in Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Outsourcing in Drug Discovery Revenue
3.4 Global Outsourcing in Drug Discovery Market Concentration Ratio
3.4.1 Global Outsourcing in Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Outsourcing in Drug Discovery Revenue in 2023
3.5 Outsourcing in Drug Discovery Key Players Head office and Area Served
3.6 Key Players Outsourcing in Drug Discovery Product Solution and Service
3.7 Date of Enter into Outsourcing in Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Outsourcing in Drug Discovery Breakdown Data by Type
4.1 Global Outsourcing in Drug Discovery Historic Market Size by Type (2019-2024)
4.2 Global Outsourcing in Drug Discovery Forecasted Market Size by Type (2025-2030)
5 Outsourcing in Drug Discovery Breakdown Data by Application
5.1 Global Outsourcing in Drug Discovery Historic Market Size by Application (2019-2024)
5.2 Global Outsourcing in Drug Discovery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Outsourcing in Drug Discovery Market Size (2019-2030)
6.2 North America Outsourcing in Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Outsourcing in Drug Discovery Market Size by Country (2019-2024)
6.4 North America Outsourcing in Drug Discovery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Outsourcing in Drug Discovery Market Size (2019-2030)
7.2 Europe Outsourcing in Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Outsourcing in Drug Discovery Market Size by Country (2019-2024)
7.4 Europe Outsourcing in Drug Discovery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Outsourcing in Drug Discovery Market Size (2019-2030)
8.2 Asia-Pacific Outsourcing in Drug Discovery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Outsourcing in Drug Discovery Market Size by Region (2019-2024)
8.4 Asia-Pacific Outsourcing in Drug Discovery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Outsourcing in Drug Discovery Market Size (2019-2030)
9.2 Latin America Outsourcing in Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Outsourcing in Drug Discovery Market Size by Country (2019-2024)
9.4 Latin America Outsourcing in Drug Discovery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Outsourcing in Drug Discovery Market Size (2019-2030)
10.2 Middle East & Africa Outsourcing in Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Outsourcing in Drug Discovery Market Size by Country (2019-2024)
10.4 Middle East & Africa Outsourcing in Drug Discovery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Detail
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Outsourcing in Drug Discovery Introduction
11.1.4 Charles River Laboratories Revenue in Outsourcing in Drug Discovery Business (2019-2024)
11.1.5 Charles River Laboratories Recent Development
11.2 ICON
11.2.1 ICON Company Detail
11.2.2 ICON Business Overview
11.2.3 ICON Outsourcing in Drug Discovery Introduction
11.2.4 ICON Revenue in Outsourcing in Drug Discovery Business (2019-2024)
11.2.5 ICON Recent Development
11.3 Parexel
11.3.1 Parexel Company Detail
11.3.2 Parexel Business Overview
11.3.3 Parexel Outsourcing in Drug Discovery Introduction
11.3.4 Parexel Revenue in Outsourcing in Drug Discovery Business (2019-2024)
11.3.5 Parexel Recent Development
11.4 PPD
11.4.1 PPD Company Detail
11.4.2 PPD Business Overview
11.4.3 PPD Outsourcing in Drug Discovery Introduction
11.4.4 PPD Revenue in Outsourcing in Drug Discovery Business (2019-2024)
11.4.5 PPD Recent Development
11.5 PRA Health Sciences
11.5.1 PRA Health Sciences Company Detail
11.5.2 PRA Health Sciences Business Overview
11.5.3 PRA Health Sciences Outsourcing in Drug Discovery Introduction
11.5.4 PRA Health Sciences Revenue in Outsourcing in Drug Discovery Business (2019-2024)
11.5.5 PRA Health Sciences Recent Development
11.6 Wuxi AppTec
11.6.1 Wuxi AppTec Company Detail
11.6.2 Wuxi AppTec Business Overview
11.6.3 Wuxi AppTec Outsourcing in Drug Discovery Introduction
11.6.4 Wuxi AppTec Revenue in Outsourcing in Drug Discovery Business (2019-2024)
11.6.5 Wuxi AppTec Recent Development
11.7 Recipharm
11.7.1 Recipharm Company Detail
11.7.2 Recipharm Business Overview
11.7.3 Recipharm Outsourcing in Drug Discovery Introduction
11.7.4 Recipharm Revenue in Outsourcing in Drug Discovery Business (2019-2024)
11.7.5 Recipharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Outsourcing in Drug Discovery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Small Molecules
Table 3. Key Players of Large Molecules
Table 4. Global Outsourcing in Drug Discovery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Outsourcing in Drug Discovery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Outsourcing in Drug Discovery Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Outsourcing in Drug Discovery Market Share by Region (2019-2024)
Table 8. Global Outsourcing in Drug Discovery Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Outsourcing in Drug Discovery Market Share by Region (2025-2030)
Table 10. Outsourcing in Drug Discovery Market Trends
Table 11. Outsourcing in Drug Discovery Market Drivers
Table 12. Outsourcing in Drug Discovery Market Challenges
Table 13. Outsourcing in Drug Discovery Market Restraints
Table 14. Global Outsourcing in Drug Discovery Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Outsourcing in Drug Discovery Market Share by Players (2019-2024)
Table 16. Global Top Outsourcing in Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Outsourcing in Drug Discovery as of 2023)
Table 17. Ranking of Global Top Outsourcing in Drug Discovery Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Outsourcing in Drug Discovery Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Outsourcing in Drug Discovery Product Solution and Service
Table 21. Date of Enter into Outsourcing in Drug Discovery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Outsourcing in Drug Discovery Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Outsourcing in Drug Discovery Revenue Market Share by Type (2019-2024)
Table 25. Global Outsourcing in Drug Discovery Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Outsourcing in Drug Discovery Revenue Market Share by Type (2025-2030)
Table 27. Global Outsourcing in Drug Discovery Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Outsourcing in Drug Discovery Revenue Market Share by Application (2019-2024)
Table 29. Global Outsourcing in Drug Discovery Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Outsourcing in Drug Discovery Revenue Market Share by Application (2025-2030)
Table 31. North America Outsourcing in Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Outsourcing in Drug Discovery Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Outsourcing in Drug Discovery Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Outsourcing in Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Outsourcing in Drug Discovery Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Outsourcing in Drug Discovery Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Outsourcing in Drug Discovery Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Outsourcing in Drug Discovery Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Outsourcing in Drug Discovery Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Outsourcing in Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Outsourcing in Drug Discovery Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Outsourcing in Drug Discovery Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Outsourcing in Drug Discovery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Outsourcing in Drug Discovery Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Outsourcing in Drug Discovery Market Size by Country (2025-2030) & (US$ Million)
Table 46. Charles River Laboratories Company Detail
Table 47. Charles River Laboratories Business Overview
Table 48. Charles River Laboratories Outsourcing in Drug Discovery Product
Table 49. Charles River Laboratories Revenue in Outsourcing in Drug Discovery Business (2019-2024) & (US$ Million)
Table 50. Charles River Laboratories Recent Development
Table 51. ICON Company Detail
Table 52. ICON Business Overview
Table 53. ICON Outsourcing in Drug Discovery Product
Table 54. ICON Revenue in Outsourcing in Drug Discovery Business (2019-2024) & (US$ Million)
Table 55. ICON Recent Development
Table 56. Parexel Company Detail
Table 57. Parexel Business Overview
Table 58. Parexel Outsourcing in Drug Discovery Product
Table 59. Parexel Revenue in Outsourcing in Drug Discovery Business (2019-2024) & (US$ Million)
Table 60. Parexel Recent Development
Table 61. PPD Company Detail
Table 62. PPD Business Overview
Table 63. PPD Outsourcing in Drug Discovery Product
Table 64. PPD Revenue in Outsourcing in Drug Discovery Business (2019-2024) & (US$ Million)
Table 65. PPD Recent Development
Table 66. PRA Health Sciences Company Detail
Table 67. PRA Health Sciences Business Overview
Table 68. PRA Health Sciences Outsourcing in Drug Discovery Product
Table 69. PRA Health Sciences Revenue in Outsourcing in Drug Discovery Business (2019-2024) & (US$ Million)
Table 70. PRA Health Sciences Recent Development
Table 71. Wuxi AppTec Company Detail
Table 72. Wuxi AppTec Business Overview
Table 73. Wuxi AppTec Outsourcing in Drug Discovery Product
Table 74. Wuxi AppTec Revenue in Outsourcing in Drug Discovery Business (2019-2024) & (US$ Million)
Table 75. Wuxi AppTec Recent Development
Table 76. Recipharm Company Detail
Table 77. Recipharm Business Overview
Table 78. Recipharm Outsourcing in Drug Discovery Product
Table 79. Recipharm Revenue in Outsourcing in Drug Discovery Business (2019-2024) & (US$ Million)
Table 80. Recipharm Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Outsourcing in Drug Discovery Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Outsourcing in Drug Discovery Market Share by Type: 2023 VS 2030
Figure 3. Small Molecules Features
Figure 4. Large Molecules Features
Figure 5. Global Outsourcing in Drug Discovery Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Outsourcing in Drug Discovery Market Share by Application: 2023 VS 2030
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Medical Laboratories Case Studies
Figure 9. Others Case Studies
Figure 10. Outsourcing in Drug Discovery Report Years Considered
Figure 11. Global Outsourcing in Drug Discovery Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Outsourcing in Drug Discovery Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Outsourcing in Drug Discovery Market Share by Region: 2023 VS 2030
Figure 14. Global Outsourcing in Drug Discovery Market Share by Players in 2023
Figure 15. Global Top Outsourcing in Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Outsourcing in Drug Discovery as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Outsourcing in Drug Discovery Revenue in 2023
Figure 17. North America Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Outsourcing in Drug Discovery Market Share by Country (2019-2030)
Figure 19. United States Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Outsourcing in Drug Discovery Market Share by Country (2019-2030)
Figure 23. Germany Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Outsourcing in Drug Discovery Market Share by Region (2019-2030)
Figure 31. China Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Outsourcing in Drug Discovery Market Share by Country (2019-2030)
Figure 39. Mexico Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Outsourcing in Drug Discovery Market Share by Country (2019-2030)
Figure 43. Turkey Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Outsourcing in Drug Discovery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Charles River Laboratories Revenue Growth Rate in Outsourcing in Drug Discovery Business (2019-2024)
Figure 46. ICON Revenue Growth Rate in Outsourcing in Drug Discovery Business (2019-2024)
Figure 47. Parexel Revenue Growth Rate in Outsourcing in Drug Discovery Business (2019-2024)
Figure 48. PPD Revenue Growth Rate in Outsourcing in Drug Discovery Business (2019-2024)
Figure 49. PRA Health Sciences Revenue Growth Rate in Outsourcing in Drug Discovery Business (2019-2024)
Figure 50. Wuxi AppTec Revenue Growth Rate in Outsourcing in Drug Discovery Business (2019-2024)
Figure 51. Recipharm Revenue Growth Rate in Outsourcing in Drug Discovery Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
